Can we quantify a safe margin to reduce local recurrence in parosteal osteosarcomas around the distal femur? A cohort study based on 27 patients

Authors

  • Kumaran Rasappan Department of Oncology and Complex Arthroplasty, Royal Orthopaedic Hospital (ROH), Birmingham, UK; Department of Orthopaedic Surgery, National University Hospital, Singapore https://orcid.org/0000-0002-9763-897X
  • Giuseppe Francesco Papalia Department of Oncology and Complex Arthroplasty, Royal Orthopaedic Hospital (ROH), Birmingham, UK; Campus Bio-Medico University of Rome, Italy https://orcid.org/0000-0002-4140-738X
  • Scott Evans Department of Oncology and Complex Arthroplasty, Royal Orthopaedic Hospital (ROH), Birmingham, UK
  • Micheal Parry Department of Oncology and Complex Arthroplasty, Royal Orthopaedic Hospital (ROH), Birmingham, UK https://orcid.org/0000-0003-0845-9257
  • Jonathan Stevenson Department of Oncology and Complex Arthroplasty, Royal Orthopaedic Hospital (ROH), Birmingham, UK https://orcid.org/0000-0002-2869-6455
  • Guy Morris Department of Oncology and Complex Arthroplasty, Royal Orthopaedic Hospital (ROH), Birmingham, UK
  • Lee Jeys Department of Oncology and Complex Arthroplasty, Royal Orthopaedic Hospital (ROH), Birmingham, UK
  • Vineet Kurisunkal Department of Oncology and Complex Arthroplasty, Royal Orthopaedic Hospital (ROH), Birmingham, UK

DOI:

https://doi.org/10.2340/17453674.2026.45943

Keywords:

Bone tumours, Local recurrence, Local recurrence free survival, Margins, Metastasis

Abstract

Background and purpose: Parosteal osteosarcoma of the distal femur usually presents as a posteriorly outgrowing tumor that lies close to the popliteal neurovascular bundle, making resection with a wide margin difficult. Tumors are often lower grade meaning surgery often forms the mainstay of treatment. We aimed to evaluate resection margins on local recurrence (LR) and metastasis-free survival rates of patients undergoing surgery for parosteal osteosarcoma of the distal femur.
Methods: This retrospective study evaluated patients with histologically confirmed parosteal osteosarcoma of the distal femur at a single institution between 2000 and 2022, with at least 2 years of follow-up. Patients undergoing primary amputation, those with distant metastases at diagnosis, and those with insufficient clinical information were excluded from the study. Data such as postoperative margins, tumor grade, LR, and metastasis was collected and analyzed.
Results: 27 patients were included. Involved margin at resection was recorded in 4 patients: a closest margin of < 1 mm in 14 and ≥ 1 mm in 9. Local recurrence (LR) occurred in 8 patients. Compared with ≥ 1 mm margins, the risk of LR was higher for involved margins (risk difference [RD] 0.75, 95% confidence interval [CI] 0.21–0.95; relative risk [RR] 14.0, CI 0.88–222) and for < 1 mm margins (RD 0.36, CI 0.00–0.61; RR 7.33, CI 0.45–119). Metastasis-free survival showed similar trends. Compared with ≥ 1 mm margins, the risk of metastasis was higher for involved margins (RD 0.25, CI −0.11 to 0.70; RR 6.0, CI 0.29–122) and for < 1 mm margins (RD 0.36, CI 0.00–0.61; RR 7.33, CI 0.45–119). There was no significant difference between the tumor grade and rate of LR.
Conclusion: A margin greater than or equal to 1 mm showed reduced LR and less metastasis in patients with parosteal osteosarcoma of the distal femur.

Downloads

Download data is not yet available.

References

Prabowo Y, Kamal A F, Kodrat E, Prasetyo M, Maruanaya S, Efar T S. Parosteal osteosarcoma: a benign-looking tumour, amenable to a variety of surgical reconstruction. Int J Surg Oncol 2020; 2020: 4807612. doi: 10.1155/2020/4807612. DOI: https://doi.org/10.1155/2020/4807612

Laitinen M, Parry M, Albergo J I, Jeys L, Abudu A, Carter S, et al. The prognostic and therapeutic factors which influence the oncological outcome of parosteal osteosarcoma. Bone Joint J 2015; 97-B(12): 1698-703. doi: 10.1302/0301-620X.97B12.35749. DOI: https://doi.org/10.1302/0301-620X.97B12.35749

Ruengwanichayakun P, Gambarotti M, Frisoni T, Gibertoni D, Guaraldi F, Sbaraglia M, et al. Parosteal osteosarcoma: a monocentric retrospective analysis of 195 patients. Hum Pathol 2019; 91:11–18. doi: 10.1016/j.humpath.2019.05.009. DOI: https://doi.org/10.1016/j.humpath.2019.05.009

Funovics P T, Bucher F, Toma C D, Kotz R I, Dominkus M. Treatment and outcome of parosteal osteosarcoma: biological versus endoprosthetic reconstruction. J Surg Oncol 2011; 103(8): 782-9. doi: 10.1002/jso.21859. DOI: https://doi.org/10.1002/jso.21859

Savvidou O D, Goumenos S, Trikoupis I, Kaspiris A, Melissaridou D, Gavriil P, et al. Oncological and functional outcomes after hemicortical resection and biological reconstruction using allograft for parosteal osteosarcoma of the distal femur. Sarcoma 2022; 2022: 5153924. doi: 10.1155/2022/5153924. DOI: https://doi.org/10.1155/2022/5153924

Pezzillo F, Maccauro G, Nizegorodcew T, Rossi B, Gosheger G. Resection of parosteal osteosarcoma of the distal part of the femur: an original reconstruction technique with cement and plate. Sarcoma 2008; 2008: 763056. doi: 10.1155/2008/763056. DOI: https://doi.org/10.1155/2008/763056

Pacheco M, Guzmán R, Bonilla P. Dedifferentiated low-grade osteosarcoma, outcome with or without chemotherapy: a systematic review. Orthop Res Rev 2023; 15: 79-89. doi: 10.2147/ORR.S404475. DOI: https://doi.org/10.2147/ORR.S404146

Tsukamoto S, Righi A, Mavrogenis A F, Masunaga T, Honoki K, Fujii H, et al. Effect of adjuvant chemotherapy on localized dedifferentiated low-grade osteosarcoma: a systematic review. Musculoskelet Surg 2024; 108(3): 241-9. doi: 10.1007/s12306-023-00795-4. DOI: https://doi.org/10.1007/s12306-024-00821-5

Christensen R, Ranstam J, Overgaard S, Wagner P. Guidelines for a structured manuscript: statistical methods and reporting in biomedical research journals. Acta Orthop 2023; 94: 243-9. doi: 10.2340/17453674.2023.11974. DOI: https://doi.org/10.2340/17453674.2023.11656

Jeys L M, Thorne C J, Parry M, Gaston C L L, Sumathi V P, Grimer J R. A novel system for the surgical staging of primary high-grade osteosarcoma: the Birmingham classification. Clin Orthop Relat Res 2017; 475(3): 842-50. doi: 10.1007/s11999-016-5099-4. DOI: https://doi.org/10.1007/s11999-016-4851-y

Ding Y, Cai Y bo, Zhang Q. [Parosteal osteosarcoma: a clinical study of 48 cases]. Zhonghua Wai Ke Za Zhi 2003; 41(11): 832-6. PMID: 14703459.

Kawaguchi N, Ahmed A R, Matsumoto S, Manabe J, Matsushita Y. The concept of curative margin in surgery for bone and soft tissue sarcoma. Clin Orthop Relat Res 2004; (419): 165-72. doi: 10.1097/00003086-200402000-00027 DOI: https://doi.org/10.1097/00003086-200402000-00027

Jamshidi K, Mirzaei A, Bagherifard A, Jahansouz A, Mohaghegh M R. Does the adherence of distal femur parosteal osteosarcoma to the neurovascular bundle increase the rate of local recurrences? Orthop Traumatol Surg Res 2022; 108(4): 103220. doi: 10.1016/j.otsr.2022.103220. DOI: https://doi.org/10.1016/j.otsr.2022.103220

Song W S, Jeon D G, Cho W H, Kong C B, Cho S H, Lee K R, et al. Clinical outcome of parosteal osteosarcoma. J Korean Bone Joint Tumor Soc 2013; 19(1): 20-7. doi: 10.5292/jkbjts.2013.19.1.20. DOI: https://doi.org/10.5292/jkbjts.2013.19.1.20

Published

2026-05-22

How to Cite

Rasappan, K., Papalia, G. F., Evans, S., Parry, M., Stevenson, J., Morris, G., … Kurisunkal, V. (2026). Can we quantify a safe margin to reduce local recurrence in parosteal osteosarcomas around the distal femur? A cohort study based on 27 patients. Acta Orthopaedica, 97, 308–312. https://doi.org/10.2340/17453674.2026.45943

Issue

Section

Publications

Categories